Home LiteratureArticle Details
PMID: 8386774 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Nm23 protein expression in ductal in situ and invasive human breast carcinoma.

Journal of the National Cancer Institute ·Vol. 85 ·No. 9 ·1993-05-05 ·Pages 727-31

Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB

Abstract

Mortality associated with human breast carcinoma is almost entirely due to subsequent metastatic disease, but the molecular basis of this metastasis is not understood. Elucidation of the genetic control of metastatic propensity of a tumor is important in determining prognosis and choice of therapy. Expression of nm23, a putative metastasis suppressor gene, has been detected in human breast cancers, but studies have not consistently shown high levels of the Nm23 messenger RNA or protein to be associated with better histological differentiation. This inconsistency suggests that Nm23 protein may act independently as a metastasis suppressor. The purpose of this retrospective study was to investigate the relationship of Nm23 protein expression with 1) histology in ductal breast carcinoma in situ and 2) the variables considered to be the major prognostic indicators in invasive breast carcinoma. We obtained formalin-fixed biopsy specimens of breast tissue excised from 128 patients with breast lesions detected by mammography. Of these patients, 35 had been diagnosed with benign breast disease, 26 with ductal carcinoma in situ (DCIS), and 67 with invasive carcinoma. Tissue sections were embedded in paraffin blocks, and immunohistochemical staining was used to determine Nm23 expression. Specimens were rated positive if all lesional epithelium was stained and negative if any lesional epithelium was unstained. Statistical analysis was performed by multiple regression analysis because of nonorthogonality of the data. All 35 examples of benign breast disease showed uniform epithelial cell staining. The seven cases of comedo DCIS were negative for Nm23 protein; all 18 noncomedo types were positive. Nm23 negativity was significantly associated with worsening invasive ductal carcinoma grade and advancing lymph node stage but not with tumor diameter or vascular invasion. Despite the putative antimetastatic role of the nm23 gene, no statistically significant association was found between Nm23 protein expression and vascular invasion. The precise role of the nm23 gene remains to be established, but our simplified immunohistochemical rating system shows an association between Nm23 protein expression and the two most significant prognostic factors relating to histologic grade and stage. Nm23 negativity distinguished comedo ductal carcinoma in situ from the other histological types, a finding consistent with the fact that comedo histology is known to have a higher likelihood of becoming invasive and of having higher cell proliferation rates and higher expression of growth factor (c-erb B2) receptor.

MeSH Terms
Breast Diseases/metabolism,pathology Breast Neoplasms/metabolism,pathology Carcinoma in Situ/metabolism Carcinoma, Intraductal, Noninfiltrating/metabolism Humans Monomeric GTP-Binding Proteins NM23 Nucleoside Diphosphate Kinases Neoplasm Proteins/metabolism Nucleoside-Diphosphate Kinase Prognosis Proteins/metabolism Regression Analysis Transcription Factors
Chemicals
NM23 Nucleoside Diphosphate Kinases Neoplasm Proteins Proteins Transcription Factors NME1 protein, human Nucleoside-Diphosphate Kinase Monomeric GTP-Binding Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Royds J A
Department of Pathology, University of Sheffield, England.
Stephenson T J
Rees R C
Shorthouse A J
Silcocks P B
Article Info
Journal
Journal of the National Cancer Institute
Abbr.
J Natl Cancer Inst
ISSN
0027-8874
Published
1993-05-05
Pages
727-31
Language
English
Region
United States
NLM ID
7503089
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com